A newly identified "blood signature" may predict lung cancer risk more than five years before diagnosis, offering a potential ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...

Tumors are heterogenous masses of cells that rapidly divide. Many cells have different mutations, functions, and ways to avoid immune cell detection and drive tumor progression. The heterogeneity of ...

Cancer is a complex disease that evades the immune system through various mechanisms. The rapid proliferation of cells and their ability to resist therapy make cancer extremely aggressive. Solid ...

A new study, the largest to date, finds an association between elevated inflammatory markers in the peripheral blood of cancer-free adults and later development of cancer, including blood, lung, and ...

By Deena Beasley June 3 (Reuters) - Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more ...

Researchers at the University of Texas at El Paso have developed a device they say can detect cancer markers in the blood with greater responsiveness than current diagnostic methods. The University of ...

Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified markers of two critical stem cell populations that drive colorectal cancer formation. Colorectal cancer is ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies. TNBC also is more likely to metastasize, or travel through the blood stream ...